Treating Blood Cancers

By Blood Cancer United

Podcast series for professionals by Blood Cancer United... more

4.8

1212 ratings

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about Treating Blood Cancers:

How many episodes does Treating Blood Cancers have?

The podcast currently has 156 episodes available.

Treating Blood Cancers episodes:

May 20, 2019 Unique Challenges for Young Adult Cancer Survivors: What You Should Know

Brad Zebrack, PhD, MSW, The University of Michigan School of Social Work, Ann Arbor, MI

Recorded on March 5, 2019

Dr. Brad Zebrack, Professor of Social Work at The University of Michigan School of Social Work in Ann Arbor, MI, shares his insights into the unique challenges faced by young adult cancer survivors. Dr. Zebrack discusses young adult survivors’ struggle for independence, challenges with body image and intimacy, issues navigating financial and career challenges, young adult survivors’ desire to feel “normal” amongst their peers, and how the healthcare team can help.

Brad Zebrack, PhD, MSW
Professor of Social Work
The University of Michigan School of Social Work
Ann Arbor, MI

...more
27min
April 16, 2019 Hearing the Patient’s Voice: A Discussion on Myelodysplastic Syndrome with a Survivor, a Caregiver, and a Physician
Richard, MDS survivor since 2016, Nancy, Caregiver, and Vu Duong, MD, University of Maryland School of Medicine, Baltimore, MD
Recorded on February 26, 2019
In this episode, Dr. Miller speaks with Richard, an MDS survivor, his wife Nancy and treating physician, Dr. Vu Duong, an Assistant Professor of Medicine at the University of Maryland School of Medicine in Baltimore, MD as they discuss their unique perspectives on the patient’s treatment for MDS and the outcomes.

Richard, MDS survior since 2016

Nancy, Caregiver

Vu Duong, MD

Assistant Professor of Medicine
University of Maryland School of Medicine
Baltimore, MD

...more
38min
April 16, 2019 Hearing the Patient’s Voice: A Discussion on Myelodysplastic Syndrome with a Survivor, a Caregiver, and a Physician

Richard, MDS survivor since 2016, Nancy, Caregiver, and Vu Duong, MD, University of Maryland School of Medicine, Baltimore, MD

Recorded on February 26, 2019

In this episode, Dr. Miller speaks with Richard, an MDS survivor, his wife Nancy and treating physician, Dr. Vu Duong, an Assistant Professor of Medicine at the University of Maryland School of Medicine in Baltimore, MD as they discuss their unique perspectives on the patient’s treatment for MDS and the outcomes.

Richard, MDS survior since 2016

Nancy, Caregiver

Vu Duong, MD
Assistant Professor of MedicineUniversity of Maryland School of MedicineBaltimore, MD

...more
38min
March 26, 2019 A Conversation on AL Amyloidosis with Dr. Raymond Comenzo, MD
Raymond Comenzo, MD, Tufts Medical Center, Boston, MA
Recorded on December 14, 2018

In this episode, Dr. Raymond Comenzo, a hematologist/oncologist at Tufts University School of Medicine in Boston, MA, breaks down the biology of AL amyloidosis, how it affects organs throughout the body, and how it is being treated in the hospital today. AL amyloidosis is a rare disorder in which there is a buildup of an abnormal protein called amyloid. Amyloid is typically produced in the bone marrow, but can be deposited in any tissue or organ causing the organ not to function properly. It is often hard to diagnose because the signs and symptoms can be the same as those of more common diseases and it is important to diagnosis as early as possible so that further organ damage is prevented. Raymond Comenzo, MD
John C. Davis Myeloma and Amyloid Program
Tufts Medical Center
Professor of Medicine
Tufts University School of Medicine
Boston, MA
...more
38min
March 26, 2019 A Conversation on AL Amyloidosis with Dr. Raymond Comenzo, MD

Raymond Comenzo, MD, Tufts Medical Center, Boston, MA

Recorded on December 14, 2018

In this episode, Dr. Raymond Comenzo, a hematologist/oncologist at Tufts University School of Medicine in Boston, MA, breaks down the biology of AL amyloidosis, how it affects organs throughout the body, and how it is being treated in the hospital today. AL amyloidosis is a rare disorder in which there is a buildup of an abnormal protein called amyloid. Amyloid is typically produced in the bone marrow, but can be deposited in any tissue or organ causing the organ not to function properly. It is often hard to diagnose because the signs and symptoms can be the same as those of more common diseases and it is important to diagnosis as early as possible so that further organ damage is prevented.

Raymond Comenzo, MD
John C. Davis Myeloma and Amyloid Program
Tufts Medical Center
Professor of Medicine
Tufts University School of Medicine
Boston, MA

...more
38min
February 25, 2019 Childhood Blood Cancers: Focus on Acute Lymphoblastic Leukemia with Dr. Lewis Silverman, MD
Lewis Silverman, MD, Boston Children’s Hospital, Boston, MA
Recorded on February 7, 2019

Learn more as Dr. Lewis Silverman, a pediatric hematologist-oncologist at Boston Children’s Hospital in Boston, MA, discusses medical advances in pediatric hematologic malignancies, the role of immunotherapy, late relapse, the role of checkpoint inhibitors, and improving the quality of cure with a focus on acute lymphoblastic leukemia.
Lewis Silverman, MD
Pediatric Hematologist-Oncologist
Boston Children’s Hospital
Boston, MA
...more
32min
February 25, 2019 Childhood Blood Cancers: Focus on Acute Lymphoblastic Leukemia with Dr. Lewis Silverman, MD

Lewis Silverman, MD, Boston Children’s Hospital, Boston, MA

Recorded on February 7, 2019

Learn more as Dr. Lewis Silverman, a pediatric hematologist-oncologist at Boston Children’s Hospital in Boston, MA, discusses medical advances in pediatric hematologic malignancies, the role of immunotherapy, late relapse, the role of checkpoint inhibitors, and improving the quality of cure with a focus on acute lymphoblastic leukemia.

Lewis Silverman, MD
Pediatric Hematologist-Oncologist
Boston Children’s Hospital
Boston, MA

...more
32min
January 18, 2019 Part II of Understanding Multiple Myeloma
Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA
Recorded on December 28, 2018

The conversation continues with Dr. Richardson in Part II of a two part episode on myeloma by describing the phases of treatment: induction remission therapy, consolidation and maintenance. Dr. Richardson provides an in-depth view of real-world issues patients experience, describes combination drug therapies and new treatments, addresses the clinical benefit of transplant for individual patients and the difference between tandem and autotransplant, and the important role of the multidisciplinary healthcare team.
Paul Richardson, MD
Clinical Program Leader
Director of Clinical Research
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, MA
...more
36min
January 18, 2019 Part II of Understanding Multiple Myeloma

Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA

Recorded on December 28, 2018

The conversation continues with Dr. Richardson in Part II of a two part episode on myeloma by describing the phases of treatment: induction remission therapy, consolidation and maintenance. Dr. Richardson provides an in-depth view of real-world issues patients experience, describes combination drug therapies and new treatments, addresses the clinical benefit of transplant for individual patients and the difference between tandem and autotransplant, and the important role of the multidisciplinary healthcare team.

Paul Richardson, MD
Clinical Program Leader
Director of Clinical Research
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, MA

...more
36min
January 18, 2019 Part I of Understanding Multiple Myeloma
Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA
Recorded on December 28, 2018

On Part I of a two part episode, Dr. Ken Miller talks with Dr. Paul Richardson, a hematologist/oncologist at Dana-Farber Cancer Center in Boston, MA, as he describes his journey as a clinical investigator and how that journey shaped his perspective when treating patients. Dr. Richardson discusses the biology of the disease, state-of-the-art care, how smoldering myeloma differs from the disease of myeloma, the use of vaccines in cancer treatment, and so much more!
Paul Richardson, MD
Clinical Program Leader
Director of Clinical Research
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, MA
...more
22min

FAQs about Treating Blood Cancers:

How many episodes does Treating Blood Cancers have?

The podcast currently has 156 episodes available.

More shows like Treating Blood Cancers

Marketplace by Marketplace

Marketplace

8,776 Listeners

The Daily by The New York Times

The Daily

111,948 Listeners

Today, Explained by Vox

Today, Explained

10,282 Listeners

VJHemOnc Podcast by VJHemOnc

VJHemOnc Podcast

2 Listeners

Blood Podcast by American Society of Hematology

Blood Podcast

51 Listeners

The Blood Cancer Experience by LLSC

The Blood Cancer Experience

0 Listeners